Skip to search formSkip to main contentSkip to account menu

Propafenone

Known as: Propafenona, Propafenone [Chemical/Ingredient], 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone 
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Overexpression of membrane bound, ATP-dependent transport proteins is one of the predominant mechanisms leading to multiple drug… 
2005
2005
Se analizo el polimorfismo del citocromo P450-2D6 mediante la determinacion del fenotipo, utilizando la ratio entre… 
2002
2002
Presentamos el caso de una mujer de 39 anos de edad con antecedentes familiares de un hermano que fallecio subitamente a la edad… 
1989
1989
The protein binding of propafenone in vitro was assessed in plasma of mouse, rat, rabbit, dog, sheep, man, cow, and horse at two… 
1987
1987
A 31-year-old female had recurring palpitations and black-outs for 13 years. Hyperthyroidism was diagnosed and electrocardiogram… 
1982
1982
A high-pressure liquid chromatographic method with internal analogue standardization is described for the determination of 2'-(2… 
1980
1980
The purpose of the present study was to determine the predictive value of serial electrophysiological testing during… 
1978
1978
Propafenone, a new anti-arrhythmia drug, was given at an average dose of 70-140 mg (1-2 mg/kg body-weight) to 124 patients with… 
1977
1977
The results of long term oral therapy of cardiac arrhythmias in 43 patients successfully treated with propafenone are reported… 
1976
1976
The pharmacologic actions of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (propafenone, SA 79) hydrochloride were…